(Q38268540)

1 September 2017

title

Treatment of acute optic neuritis and vision complaints in multiple sclerosis (English)

1 reference

1 September 2017

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399875%20AND%20SRC:MED&resulttype=core&format=json

Bernardo F. Sanchez-Dalmau

8 June 2020

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399875%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Ruben Torres-Torres

1 reference

1 September 2017

Bernardo F Sanchez-Dalmau

series ordinal

1 reference

1 September 2017

publication date

1 January 2015

1 reference

Current treatment options in neurology

1 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399875%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399875%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399875%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25399875%20AND%20SRC:MED&resulttype=core&format=json

Acute demyelinating optic neuritis

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

The visual pathway as a model to understand brain damage in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Clinical profile of simultaneous bilateral optic neuritis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Plasma exchange for severe optic neuritis: treatment of 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

The symptomatic Pulfrich phenomenon can be successfully managed with a coloured lens in front of the good eye--a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

The Pulfrich phenomenon; clumsiness and collisions which can be ameliorated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Unusual symptoms and syndromes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Visual issues in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Internuclear ophthalmoplegia: causes and long-term follow-up in 65 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

The neuro-ophthalmology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Drug therapy for acquired pendular nystagmus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Drug treatments for eye movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Surgical treatment of upgaze palsy in Parinaud's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Paroxysmal convergence spasm in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Intravenous immunoglobulin: adverse effects and safe administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Interferon-associated combined branch retinal artery and central retinal vein obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-014-0328-Z

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadi

21 January 2018

1 reference

12 December 2020

Neuro-ophthalmologic aspects of multiple sclerosis: Using eye movements as a clinical and experimental tool.

1 reference

12 December 2020

A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis

1 reference

12 December 2020

Internuclear ophthalmoplegia: pathophysiology and diagnosis

1 reference

12 December 2020

The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group

1 reference

12 December 2020

Interferon-associated retinopathy and cystoid macular edema

1 reference

12 December 2020

Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis

1 reference

12 December 2020

Eye disorders in patients with multiple sclerosis: natural history and management

1 reference

12 December 2020

Ocular Effects of Topical and Systemic Steroids

1 reference

12 December 2020

A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis

1 reference

12 December 2020

Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration

1 reference

12 December 2020

Current Treatment of Nystagmus

1 reference

12 December 2020

Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging

1 reference

12 December 2020